Grape King Bio (TPE:1707) Cyclically Adjusted FCF per Share: NT$14.61 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:1707 Grape King Bio Ltd TPE:1707
79 GF Score
Price NT$92.70
GF Value NT$144.12
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Grape King Bio Cyclically Adjusted FCF per Share?

Grape King Bio TPE:1707 +1.98% 79 Cyclically Adjusted FCF per Share is NT$14.61 as of Dec. 2025. GuruFocus rates TPE:1707 with a GF Score™ of 79/100 and a GF Value™ of NT$144.12 (Possible Value Trap). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Grape King Bio's adjusted free cash flow per share for the three months ended in Dec. 2025 was NT$6.929. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$14.61 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Grape King Bio's average Cyclically Adjusted FCF Growth Rate was 24.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 8.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Grape King Bio was 15.60% per year. The lowest was 5.10% per year. And the median was 11.20% per year.

As of today (2026-07-20), Grape King Bio's current stock price is NT$92.70. Grape King Bio's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2025 was NT$14.61. Grape King Bio's Cyclically Adjusted Price-to-FCF of today is 6.34.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Grape King Bio was 33.54. The lowest was 6.22. And the median was 14.24.


Grape King Bio  (TPE:1707) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Grape King Bio's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=92.70/14.61
=6.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Grape King Bio was 33.54. The lowest was 6.22. And the median was 14.24.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Grape King Bio Cyclically Adjusted FCF per Share Related Terms


Grape King Bio Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Grape King Bio's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grape King Bio Cyclically Adjusted FCF per Share Chart

Grape King Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.09 11.41 11.85 11.73 14.61

Grape King Bio Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.73 11.65 13.97 14.77 14.61

TPE:1707 vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grape King Bio's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Grape King Bio Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grape King Bio's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Grape King Bio's Cyclically Adjusted Price-to-FCF falls into.


TPE:1707
79GF Score
Grape King Bio Ltd TPE:1707
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Grape King Bio Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Grape King Bio's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=6.929/324.0540*324.0540
=6.929

Current CPI (Dec. 2025) = 324.0540.

Grape King Bio Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201603 1.586 238.132 2.158
201606 3.076 241.018 4.136
201609 4.218 241.428 5.662
201612 6.151 241.432 8.256
201703 1.436 243.801 1.909
201706 0.607 244.955 0.803
201709 2.834 246.819 3.721
201712 7.736 246.524 10.169
201803 -1.527 249.554 -1.983
201806 0.934 251.989 1.201
201809 3.345 252.439 4.294
201812 6.721 251.233 8.669
201903 -1.424 254.202 -1.815
201906 3.297 256.143 4.171
201909 0.881 256.759 1.112
201912 8.320 256.974 10.492
202003 -1.026 258.115 -1.288
202006 -0.009 257.797 -0.011
202009 1.928 260.280 2.400
202012 9.964 260.474 12.396
202103 0.344 264.877 0.421
202106 4.187 271.696 4.994
202109 1.875 274.310 2.215
202112 8.782 278.802 10.207
202203 0.030 287.504 0.034
202206 7.583 296.311 8.293
202209 -1.065 296.808 -1.163
202212 10.144 296.797 11.076
202303 -0.496 301.836 -0.533
202306 6.073 305.109 6.450
202309 -2.170 307.789 -2.285
202312 9.438 306.746 9.971
202403 -0.251 312.332 -0.260
202406 -0.369 314.175 -0.381
202409 1.804 315.301 1.854
202412 7.025 315.605 7.213
202503 -0.550 319.799 -0.557
202506 4.811 322.561 4.833
202509 0.306 324.800 0.305
202512 6.929 324.054 6.929

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of NT$14.61 mean?
Grape King Bio (TPE:1707) has a Cyclically Adjusted FCF per Share of NT$14.61 as of Dec. 2025. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Grape King Bio and its competitors.
Is Grape King Bio's Cyclically Adjusted FCF per Share too high?
Grape King Bio's current Cyclically Adjusted FCF per Share is NT$14.61. Overall, Grape King Bio has a GF Score™ of 79/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Grape King Bio's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
Grape King Bio's Cyclically Adjusted FCF per Share of NT$14.61 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Grape King Bio and its competitors. Grape King Bio's current Cyclically Adjusted FCF per Share is NT$14.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Grape King Bio stock overvalued right now?
Based on GuruFocus' analysis, Grape King Bio (TPE:1707) is currently considered Possible Value Trap. The stock's GF Value™ is NT$144.12, compared to a current price of NT$92.70 — trading 35.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is NT$14.61. Grape King Bio's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Grape King Bio (TPE:1707), the current Cyclically Adjusted FCF per Share is NT$14.61 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Grape King Bio (TPE:1707) Overvalued in 2026?

Based on GuruFocus' analysis, Grape King Bio stock appears to be undervalued. The current stock price of NT$92.70 is trading 35.7% below its estimated GF Value™ of NT$144.12. GuruFocus considers Grape King Bio to be Possible Value Trap.

Key valuation signals for TPE:1707:

  • Cyclically Adjusted FCF per Share: NT$14.61
  • GF Value™: NT$144.12 vs. price of NT$92.70 (35.7% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the TPE:1707 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Grape King Bio Business Description

Address Jinling Road, No. 402, Section 2, Pingzhen District, Pingzhen District, Taoyuan, TWN, 324
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in producing and selling pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food. The company has three segments: MLM (Multi-Level Marketing), which is a direct seller of Pro-partner Inc, including the company's development and manufacturing products for Pro-partner Inc, the Distributors segment includes the company's self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others, and it derives a majority of its revenue from Taiwan.
79GF Score

Get the complete analysis for TPE:1707

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$92.70
Price
NT$144.12
GF Value